Development and Validation of a Novel LC-MS/MS-Based Proteomics Method for Quantitation of Retinol Binding Protein 4 (RBP4) and Transthyretin (TTR)
- 10 September 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (10) , 5266-5276
Abstract
Retinol binding protein 4 (RBP4), the circulating carrier of retinol, complexes with transthyretin (TTR) and is a potential biomarker of cardiometabolic disease. However, RBP4 quantitation relies on immunoassays and Western blots without retinol and TTR measurement. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous absolute quantitation of circulating RBP4 and TTR is critical to establishing their biomarker potential. Surrogate peptides with reproducible, linear LC-MS/MS response were selected. Purified proteins were used as quantitation standards and heavy-labeled peptides as internal standards. Matrix effects were evaluated. The validated method was applied to measure inter- and intraindividual variability in RBP4 and TTR concentrations in healthy individuals and patients with diabetic kidney disease. Quantitation was linear for the clinically relevant concentration ranges of RBP4 (0.5-6 μM) and TTR (5.8-69 μM). Assay interday variability was <12% and precision within 5%. The interindividual variability for RBP4 and TTR concentrations was 18-26%, while intraindividual variability was similar to assay variability. RBP4 and TTR quantitation correlated with commercially available enzyme-linked immunoassays (ELISA) assays. The developed LC-MS/MS method enables simultaneous absolute quantitation of RBP4 and TTR in serum and plasma. It can be applied to clinical biomarker studies and stoichiometric measurements of circulating RBP4, TTR, and retinol.Keywords
All Related Versions
Funding Information
- National Center for Advancing Translational Sciences (UL1TR002319)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK07047)
- National Institutes of Health (P01-DA032507, R01-GM111772, T32-GM007750, TL1-TR002318)
This publication has 36 references indexed in Scilit:
- Small volume retinol binding protein measurement by liquid chromatography-tandem mass spectrometryClinical Biochemistry, 2021
- Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disordersPharmacology & Therapeutics, 2019
- The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomicsMass Spectrometry Reviews, 2017
- Quantitative analysis of post-translational modifications in human serum transthyretin associated with familial amyloidotic polyneuropathy by targeted LC–MS and intact protein MSJournal of Proteomics, 2015
- Hepatic metabolism of retinoids and disease associationsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Protease inhibitors as possible pitfalls in proteomic analyses of complex biological samplesJournal of Proteomics, 2011
- The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometryJournal of Immunological Methods, 2009
- Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjectsDiabetologia, 2007
- Plasma Retinol-Binding Protein1984
- Vitamin A in Animal and Human Nutrition1984